<DOC>
	<DOCNO>NCT00780897</DOCNO>
	<brief_summary>Premature Ovarian Failure ( POF ) , syndrome observe young woman , present consequence hormonal lead definitive infertility . It 's rare complex syndrome reason , propose initiate collaborative team network understand well genetic physiopathology . We go realize global study syndrome clinical fundamental approach . We wish project allow u understand good physiopathology rare disease . Finally , POF responsible gene identification base future development therapeutic approach .</brief_summary>
	<brief_title>Premature Ovarian Failure ( Genetic Physiopathologic Analysis )</brief_title>
	<detailed_description>Premature ovarian failure ( POF ) rare exceptional disease concern 0.1 % more-than-thirty-years-old woman . On clinical aspect , patient present primary secondary amenorrhea depend disease occur live . Infertility time definitive yet available therapy auto implantation cryopreserved oocyte . Initiation substitutive hormonal treatment also necessary prevent consequence estrogenic hardship ( i.e lead osteoporosis ) . POF numerous possible origin , link auto-immune disease , metabolic disorder ( i.e . galactosemia ) even genetic abnormality . According origin , POF characterize ( ) depletion primary follicle , ( b ) increase accelerated follicle atresia ( c ) alteration recruitment dominant follicle ( ) stop follicular maturation . The purpose work organize clinical fundamental research network focus premature ovarian failure ( POF ) . It aim collect clinical , biological , radiological histological information patient , accord phenotype , decide search possible genetic abnormality lead POF . And time , constitution broad tissue collection allow study ovarian transcript , use POF pathologic model describe ovary follicle development-involved gene .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<mesh_term>Menopause , Premature</mesh_term>
	<criteria>Inclusion criterion : Experimental group : 18 year &lt; Age &gt; 39 year Patient amenorrhea since least 3 month Patient least 1 FSH dosage &gt; 30 mUI/L Patients 40 45 year old hormonal result indicate POF declare 39 year old include . Informed Consent Form Signature Control group : 18 year &lt; Age &gt; 39 year Patient benign ovarian pathology justify ovarian surgery Informed Consent Form Signature Exclusion criterion :</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>PREMATURE OVARIAN FAILURE ( POF )</keyword>
	<keyword>GENETIC ANALYSIS</keyword>
	<keyword>PHYSIOPATHOLOGIC ANALYSIS</keyword>
</DOC>